Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's "Halftime Report" to discuss his latest trade out of Sharkninja, and how he's thinking about Pfizer at these levels..
Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's "Halftime Report" to discuss his latest trade out of Sharkninja, and how he's thinking about Pfizer at these levels.
Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's "Halftime Report" to discuss his latest trade out of Sharkninja, and how he's thinking about Pfizer at these levels..